159 related articles for article (PubMed ID: 7558435)
1. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
2. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Silletti S; Timar J; Honn KV; Raz A
Cancer Res; 1994 Nov; 54(22):5752-6. PubMed ID: 7954394
[TBL] [Abstract][Full Text] [Related]
3. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
4. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
5. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
6. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Lotan R; Amos B; Watanabe H; Raz A
Cancer Res; 1992 Sep; 52(18):4878-84. PubMed ID: 1325286
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mapping.
Silletti S; Yao J; Sanford J; Mohammed A; Otto T; Wolman S; Raz A
Int J Oncol; 1993 Nov; 3(5):801-7. PubMed ID: 21573434
[TBL] [Abstract][Full Text] [Related]
8. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
9. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
10. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Nabi IR; Watanabe H; Raz A
Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
12. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
Fairbank M; St-Pierre P; Nabi IR
Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Niinaka Y; Haga A; Negishi A; Yoshimasu H; Raz A; Amagasa T
Oral Oncol; 2002 Jan; 38(1):49-55. PubMed ID: 11755821
[TBL] [Abstract][Full Text] [Related]
14. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
15. Multiple use of a signal transduction pathway in tumor cell invasion.
Tímár J; Rásó E; Fazakas ZS; Silletti S; Raz A; Honn KV
Anticancer Res; 1996; 16(6A):3299-306. PubMed ID: 9042304
[TBL] [Abstract][Full Text] [Related]
16. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
17. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
Tímár J; Rásó E; Döme B; Ladányi A; Bánfalvi T; Gilde K; Raz A
Clin Exp Metastasis; 2002; 19(3):225-32. PubMed ID: 12067203
[TBL] [Abstract][Full Text] [Related]
19. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Nakamori S; Watanabe H; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Raz A
Cancer; 1994 Oct; 74(7):1855-62. PubMed ID: 8082090
[TBL] [Abstract][Full Text] [Related]
20. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Timar J; Silletti S; Bazaz R; Raz A; Honn KV
Int J Cancer; 1993 Dec; 55(6):1003-10. PubMed ID: 8253518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
